A simple technique to identify key recruitment issues in randomised controlled trials: Q-QAT - quanti-qualitative appointment timing by unknown
TRIALS
Paramasivan et al. Trials  (2015) 16:88 
DOI 10.1186/s13063-015-0617-1RESEARCH Open AccessA simple technique to identify key recruitment
issues in randomised controlled trials:
Q-QAT - quanti-qualitative appointment timing
Sangeetha Paramasivan1, Sean Strong1, Caroline Wilson1, Bruce Campbell2, Jane M Blazeby1
and Jenny L Donovan1*Abstract
Background: Recruitment to pragmatic randomised controlled trials (RCTs) is acknowledged to be difficult, and few
interventions have proved to be effective. Previous qualitative research has consistently revealed that recruiters
provide imbalanced information about RCT treatments. However, qualitative research can be time-consuming to
apply. Within a programme of research to optimise recruitment and informed consent in challenging RCTs, we
developed a simple technique, Q-QAT (Quanti-Qualitative Appointment Timing), to systematically investigate and
quantify the imbalance to help identify and address recruitment difficulties.
Methods: The Q-QAT technique comprised: 1) quantification of time spent discussing the RCT and its treatments
using transcripts of audio-recorded recruitment appointments, 2) targeted qualitative research to understand the
obstacles to recruitment and 3) feedback to recruiters on opportunities for improvement. This was applied to two
RCTs with different clinical contexts and recruitment processes. Comparisons were made across clinical centres,
recruiters and specialties.
Results: In both RCTs, the Q-QAT technique first identified considerable variations in the time spent by recruiters
discussing the RCT and its treatments. The patterns emerging from this initial quantification of recruitment appointments
then enabled targeted qualitative research to understand the issues and make suggestions to improve recruitment.
In RCT1, presentation of the treatments was balanced, but little time was devoted to describing the RCT. Qualitative
research revealed patients would have considered participation, but lacked awareness of the RCT. In RCT2, the balance
of treatment presentation varied by specialists and centres. Qualitative research revealed difficulties with equipoise and
confidence among recruiters presenting the RCT. The quantitative and qualitative findings were well-received by
recruiters and opportunities to improve information provision were discussed. A blind coding exercise across three
researchers led to the development of guidelines that can be used to apply the Q-QAT technique to other difficult RCTs.
Conclusion: The Q-QAT technique was easy to apply and rapidly identified obstacles to recruitment that could be
understood through targeted qualitative research and addressed through feedback. The technique’s combination of
quantitative and qualitative findings enabled the presentation of a holistic picture of recruitment challenges and added
credibility to the feedback process.
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Challenges in recruiting to pragmatic randomised con-
trolled trials (RCTs) evaluating health technologies and
services have been well-documented [1-3]. Some strategies
to facilitate recruitment through good clinical practice
have been identified [4], but systematic reviews have
shown that only a small number of interventions to im-
prove recruitment have been robustly evaluated and even
fewer are effective [5,6]. A complex intervention using pri-
marily qualitative research methods was developed and
applied within the ProtecT (Prostate testing for cancer
and Treatment) trial, leading to improved and ultimately
successful recruitment [7,8]. An adapted version of this
intervention was applied within five further RCTs [9] lead-
ing to successful recruitment in some trials [10] and evi-
dence to support a decision to close others [11,12]. A
synthesis of the findings that emerged from applying the
intervention in these RCTs also provided a detailed under-
standing of the clear and hidden challenges to recruitment
[13] and the fragility of the recruitment process [14].
The intervention comprises methods that can be time-
consuming to apply, while RCTs often have time-limited
recruitment periods within which to apply interventions;
an aspect that has previously proved challenging [11].
There is an urgent need to develop interventions that
are simple to apply and can rapidly ensure effective and ef-
ficient recruitment of appropriately informed participants
to trials. We are undertaking a programme of mixed
methods research with two major aims: first to understand
recruitment issues as they happen in a wide range and in-
creasing number of pragmatic RCTs [8,9]; and second, to
use those nuanced understandings to design components
of a complex intervention that could then be assembled to
tackle recruitment difficulties in most RCTs. Within this
programme, we developed a simple technique - Quanti-
Qualitative Appointment Timing (Q-QAT) - to swiftly
identify key challenges to recruitment that stem from how
the RCT and treatments are portrayed to patients in re-
cruitment appointments (the consultation where RCT in-
formation is provided to patients), so that these issues can
be fully investigated and suggestions made to improve re-
cruitment. The derivation and development of the tech-
nique, its application in two very different RCTs, and
some guidance about how it can be applied to RCTs
undertaking recruitment, are presented in this paper.
Methods
Development of the Q-QAT technique
The principles underlying the Q-QAT technique first
emerged in the analysis of audio-recorded recruitment
appointments in the ProtecT trial feasibility study. It was
noted that one among the key factors inhibiting recruit-
ment in this study was the lack of balance in the presen-
tation of the treatments to patients. For instance, recruiterspresented the trial treatments in a particular order (sur-
gery, radiotherapy and, finally, monitoring), at different
lengths and with different degrees of enthusiasm (monitor-
ing presented more briefly and with less enthusiasm than
the other two treatments), meaning that very few potential
participants were willing to be randomised [7]. When re-
cruiters were given suggestions to correct this imbalanced
presentation of treatments (among other aspects of the
complex intervention) [7], recruitment improved [8]. As
similar imbalances in the presentation of RCT treatments
were also found in other RCTs [10,11], we set out to de-
velop a simple technique, Q-QAT, with three main aims:
a) to systematically investigate, quantify and qualitatively
explore these imbalances, b) to assess the practicality of
the Q-QAT technique, its acceptability amongst recruiters,
and its potential usefulness as an intervention to improve
recruitment and c) to develop guidelines to allow easy fu-
ture application of the technique.
Application of the Q-QAT technique in two RCTs
The Q-QAT technique was further developed and stan-
dardised within two RCTs.
Setting - the RCTs
The two RCTs were pragmatic, publicly-funded studies that
differed in terms of organisational issues and complexity of
the recruitment process so that they would test the tech-
nique (Table 1). In RCT1, there was one specialty (surgery)
involved, it compared surgery and a minimally invasive
technique to treat an elective problem, and had a relatively
simple recruitment process comprising an appointment
with a surgeon where the trial was discussed, with a face-to-
face or telephone follow-up by a research nurse. In contrast,
RCT2 involved two clinical specialties (surgery and oncol-
ogy), compared surgery and radiotherapy to treat a life-
threatening cancer (all patients had chemotherapy first), and
had a more complex recruitment process in which patients
had separate appointments with each specialist before being
asked to consider participation in the RCT. In both RCTs,
patients were given the trial information sheet at the ap-
pointments to take home and consider. The research nurse
usually called after a week to elicit the patient’s decision.
The RCTs were also at different stages, and with different
degrees of collaboration with the Q-QAT team. In RCT1,
recruitment to the full trial was underway, but, with con-
cerns about low levels of recruitment, the CI permitted a
small nested qualitative study in one centre to investigate
this. In RCT2, which was a feasibility study, there was a
fully-funded integrated qualitative study modelled on previ-
ous qualitative research in trials applied to all three centres
[8]. Ethical approval was obtained for the qualitative study
as an amendment for RCT1, and integrated into the ap-
proval for RCT2. The names of the approving bodies cannot
be provided because the two RCTs asked to be anonymised.
Table 1 Characteristics of the randomised controlled trials (RCTs) used to develop the Quanti-Qualitative Appointment
Timing (Q-QAT) technique
RCT1 RCT2
Context Elective procedure, not life-threatening Life-threatening cancer
Specialties Surgery Surgery and oncology
Treatment groups Standard surgery versus minimally invasive procedure Chemotherapy plus either surgery or radiotherapy
Centres for qualitative research 1 3
Clinicians who provided
audio-recordings
3 surgeons; 1 research nurse Centre 1: 4 surgeons, 2 oncologists
Centre 2: 1 surgeon, 2 oncologists
Centre 3: none
Recruitment process Treatment options and recruitment discussion by surgeon,
in the same appointment as history-taking, diagnosis and
examination. Sometimes follow-up by nurse
Dedicated appointments for treatment options and
recruitment discussion. Separate appointments with
surgeon and with oncologist
Number of consultation
audio-recordings obtained
13 with surgeons Total: 26 pairs
8 with research nurse (Centre 1: 19 pairs, Centre 2: 7 pairs, Centre 3: none)
Q-QAT applied to 13 surgeon appointments Total: 11 pairs
(Centre 1: 7 pairs, Centre 2: 4 pairs)
Number of interviews 5 patient interviews 18 interviews with 16 patients
Unrecorded discussions with CI (Centre 1: 9, Centre 2: 3, Centre 3: 4)
20 staff interviews
(Centre 1: 10, Centre 2: 4, Centre 3: 6)
Unrecorded discussions with CI
Abbreviation: CI Chief Investigator.
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Informed consent was obtained from patients and RCT staff
prior to the audio-recording of consecutive recruitment ap-
pointments and in-depth interviews. Digital recorders were
delivered to participating centres with instructions for use
to facilitate audio-recording of recruitment appointments.
In-depth interviews were conducted with a purposive sam-
ple of patients in both RCTs as well as staff in RCT2, using
a semi-structured approach and topic guides based on pre-
vious studies [8,9]. In both RCTs, patients were interviewed
after their recruitment appointment and after they had
made a decision on trial participation. They were asked
about their views on the information provided at the re-
cruitment appointment and the key issues that influenced
their decision-making process in relation to trial participa-
tion. In RCT2, staff interviews were conducted during re-
cruitment and participants were asked about their views on
the RCT and its treatments, challenges to recruitment and
ways to overcome them. Interviews with staff were not
undertaken in RCT1 because of resource constraints. Inter-
views, Q-QAT application and analysis in RCT1 were car-
ried out by SP and in RCT2 by SS and CW.
Data analysis: Q-QAT elements
Recruitment-related parts of the audio-recordings of re-
cruitment appointments and all parts of the interviews
were transcribed. The Q-QAT technique was then appliedto eligible patients’ recordings in three ways, each of which
is described in detail below.
1. Q-QAT quantification: the following aspects were
coded and quantified in transcripts of recruitment
appointments:
(a)Time taken by recruiters to present the details of
each of the RCT treatments (mean, median,
range; by centre, recruiter, specialty as applicable)
(b)Time taken by recruiters to explain the design,
purpose and procedures of the RCT (mean,
median, range; by centre, recruiter, specialty
as applicable)
(c)Total length of appointment
2. Targeted qualitative analysis: the findings from the
Q-QAT quantification process informed the targeted
exploration of issues during the qualitative analysis.
The recruitment appointments and interviews were
thematically analysed using constant comparative
techniques from grounded theory [15], drawing on
methods that had been used in similar previous
studies [8,9].
(a)Recruitment appointments were analysed to
understand the barriers to recruitment in
appointments
(b)Interviews were analysed to understand the views
of recruiters and/or patients about the RCT and
Fig
Tran
Paramasivan et al. Trials  (2015) 16:88 Page 4 of 15recruitment difficulties, and to assess the
acceptability and usefulness of the Q-QAT
technique with the RCT Chief Investigator (CI),
centre Principal Investigators (PIs) and recruiters3. Feedback: findings from the analysis in 1 and 2
above were synthesised and discussed with the RCT
CI in the first instance. Presentations were then
made to groups of recruiters in face-to-face meetings
informing them of the anonymised findings and
identifying opportunities to improve recruitment.
These methods were investigated first in RCT1, which
had a simpler recruitment process, and then applied and
further refined in RCT2, which was more complex.
Development of guidelines for future application of the
Q-QAT technique
In order to refine and standardise the technique for fu-
ture use, 3 researchers (SP, SS and CW) separately coded
a sub-sample of 6 appointments (2 in RCT1 and 4 in
RCT2) and then compared the codes to develop the
consistency and reliability of the Q-QAT coding strategy.
During this process of blind coding, in addition to the as-
pects of time identified above (time taken to present the
RCT treatments and the RCT), other key aspects of re-
cruitment (such as balancing of treatments) were identifiedure 1 Example of transcript with Quanti-Qualitative Appointment
scripts were coded with time markings that denoted when a particular coand assessed for their importance and ability to be added
to the Q-QAT technique. Coding challenges such as over-
lapping topics of conversation and quick comparisons of
treatments where recruiters frequently moved from one
treatment to another were specifically considered. Regular
meetings were held amongst the researchers to refine the
codes, resolve discrepancies and develop guidelines for the
use of the Q-QAT technique. The final version of the
guidelines is provided in detail below and an example of a
transcript with Q-QATcoding is provided in Figure 1.
Results
Application of the Q-QAT technique in RCT1 and RCT2
In RCT1, there were 13 audio-recordings of recruitment
appointments with surgeons in 1 centre and in RCT2, 26
pairs of recruitment appointments, each with an oncolo-
gist and surgeon in 2 centres (Table 1). Recruitment to the
RCTs had been very limited at the time of Q-QATapplica-
tion. All recordings during the Q-QAT study were with
eligible patients. The Q-QAT technique was applied to all
13 appointments in RCT1; in RCT2, it was applied to the
first 11 pairs of recordings to be able to provide rapid
feedback to recruiters.
In RCT1, there were 8 follow-up appointments with
the research nurse and 5 interviews with patients, and in
RCT2, there were 20 interviews with recruitment staffTiming (Q-QAT) coding from randomised controlled trial 1 (RCT1).
de began and ended. An example of how this was done is shown here.
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for each RCT separately.
Findings from RCT1
1. Q-QAT quantification
Three surgeons provided at least 4 recordings each in
RCT1 (Table 2). The appointments ranged in length from
around 9 to 29 minutes (mean 17:02; median 16:22).
The Q-QAT table in RCT1 shows the time breakdown
for a total of 13 recordings with 3 surgeons. The total
time of the recording and the time spent on describing
the treatments (surgery and minimally invasive proced-
ure) and the RCT were recorded. The remainder of the
time was spent on other aspects such as history-taking,
examination, diagnosis and non-RCT related treatment
information.
(a)Time taken by recruiters to present the details of
each of the RCT treatments: the description of
surgery ranged from ‘no discernible discussion’ to
around 2 minutes (mean 00:54, median 00:44). The
description of the minimally invasive technique
ranged from 13 seconds to around 5 minutes (mean
01:54, median 01:10). Surgeons, on average, spent a
little more time discussing the minimally invasive
technique than surgery, although this imbalance
was most evident in 6 of the 13 appointments
(appointments 5, 7, 9, 10, 12 and 13).Table 2 Randomised controlled trial 1 (RCT1) Quanti-Qualitat
seconds
Patients Recruiters Total time Surgery
Patient 1 Surgeon X 12:54 00:35
Patient 2 Surgeon X 16:22 00:29
Patient 3 Surgeon X 18:51 01:13
Patient 4 Surgeon X 29:14 00:44
Patient 5 Surgeon X 19:59 00:43
Patient 6 Surgeon Y 11:28 00:53
Patient 7 Surgeon Y 17:43 00:31
Patient 8 Surgeon Y 12:46 00:48
Patient 9 Surgeon Y 15:33 00:32
Patient 10 Surgeon Z 12:15 00:00
Patient 11 Surgeon Z 08:58 02:00
Patient 12 Surgeon Z 24:16 02:20
Patient 13 Surgeon Z 21:09 00:56
Mean 17:02 00:54
Median 16:22 00:44
Range 08:58 to 29:14 00:00 to(b)Time taken by recruiters to explain the design,
purpose and procedures of the RCT: discussion
about the RCT ranged from 28 seconds to just over
3 minutes (mean 1:50, median 1:46). Comparing
recruitment rates and time spent on the RCT,
surgeon X, with the lowest recruitment rate (7%,
13/183) spent the least amount of time explaining
the RCT (mean 01:14), whereas surgeon Z, with the
highest recruitment rate (19%, 19/99) spent the
greatest amount of time discussing the RCT (mean
02:36). Surgeon Y was between the others on both
counts (RCT mean 02:09; recruitment rate 13.6%,
19/140).
In summary, some preliminary conclusions and
questions worthy of further investigation could be
drawn from the simple Q-QAT quantification above in
RCT1. First, the reasons why surgeons spent a little
more time, on average, describing the minimally inva-
sive technique, and why this was more marked in some
appointments than others, could be explored. Second,
very little time was spent discussing either the RCT or
its treatments, compared with other information or ac-
tivity in the appointments, and the impact of this on
recruitment was identified as important to investigate.
Also, although there were only a small number of re-
cordings, there seemed to be a relationship between
time spent explaining the RCT and recruitment suc-
cess. Each of these issues was explored in the qualita-
tive analysis below.ive Appointment Timing (Q-QAT) timings in minutes:
















02:20 00:13 to 05:06 00:28 to 03:08
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(a) Insights from recruitment appointments
The qualitative analysis revealed that the reason for less
time devoted to surgery, identified by the Q-QAT analysis
in some appointments, was because surgeons provided
minimal information for patients with previous experience
of the procedure (appointments 5, 10, 13) and used the
time to explain the recent advances in minimally invasive
treatment (appointment 9). In 7 of the 13 appointments,
there was a good time balance between treatments, which
reflected the way in which the treatments were portrayed:
Surgeon Z: there are good things about T(a); there are
good things about T(b).
Surgeon Y: we know they both work perfectly well, it’s
just that there’s different things to them. On the one
hand, one has an anaesthetic, the other doesn’t. One,
uh, you know, you’ve got to wear some bandages for
longer, one you are left with (problem) for longer, but
you haven’t had an anaesthetic, and there’s all these
pros and cons, and we really don’t know whether one
is better than the other.
This kind of balanced information about treatments pre-
pared patients to be recruited to the RCT, but the quali-
tative analysis confirmed that the majority of time in
RCT1 appointments was spent on history-taking, examin-
ation, diagnosis and non-RCT related treatment informa-
tion, with very little being said about the RCT itself.
Surgeons tended to present the RCT briefly and awk-
wardly, sometimes as an option only for patients who did
not have a treatment preference:
Surgeon X: if you didn’t decide (on the treatment) or
couldn’t decide which way you’d like to go with your
choice, or you’re happy to leave your choice open to us,
we are randomising people.
When they did mention the RCT, they struggled to
present it clearly and complete recruitment. In the ap-
pointment below, the patient repeatedly indicated her
equipoise by stating she had ‘no favourite’ treatment, was
‘ambivalent’ and expressed a positive attitude towards the
study and the 5-year follow-up provided. However, she
was asked to consider the study only if she could not make
her mind up, with a subtle remark that she may think the
study was ‘too much bother’ (patient’s interpretation of this
discussion is presented in section 2(b) below):
Surgeon Z: and if you go into the study, it would involve
us opening an envelope at random so to speak and it
will say treatment (a) or treatment (b). We then do thetreatment and follow you up afterwards for 5 years to
make sure.
Patient 11: yeah, that’s interesting.
Surgeon Z: it won’t involve a lot of visits or extra time
(explains follow-up questionnaires for five lines). So the
most important thing is that if you decide you’d rather
have treatment (a) or you’d rather have treatment (b)…
Patient 11: I’m pretty ambivalent really.
Surgeon Z: yes, well just don’t make that decision in
front of me today. And if you can’t make your mind
up, consider the study, but if you don’t want to do the
study ‘cause you’re thinking it might be too much
bother, you don’t have to give us a reason, it will not
alter the way we feel about you in anyway. It’s simple,
you can walk away at any time.
Patient 11: excellent.
Exploring the relationship between time spent discuss-
ing the RCT and recruitment success across surgeons was
difficult because no patients had agreed to participate in
the RCT during the time of Q-QAT analysis. However, the
recordings of patients who declined revealed that the extra
time spent by surgeon Z provided the scope to address
questions, explain the study positively and in detail, in-
cluding aspects of follow-up and benefits of study partici-
pation, which were discussed to a far lesser extent or not
at all by the other surgeons.
The qualitative analysis also raised questions about who
discussed the RCT in detail. Following their limited dis-
cussion or mention of the RCT, the surgeons often ended
the appointments by suggesting that the patient should
discuss the issues further with the research nurse involved
in the study. The conversations with the nurse (usually on
the telephone), however, were very short and focused only
on patients’ travel plans, appointment arrangements, and
their decision about choice of treatment rather than any
discussion about trial participation:
Research Nurse (RN): after initial introductions) It’s
just a follow-up call to see if you’ve had a chance to
read through the information you were given about the
treatment options.
P8: I have yes.
RN: yes. What would you like to do?
P8: what I’ve decided I wanna do is, if possible is to
have the operation if that’s alright.
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Interviews with patients confirmed the consequences of
the Q-QAT findings. Because very little time was spent
discussing the RCT, patients had little if any understand-
ing of what trial participation or randomisation involved.
Two patients who wanted to participate in the study be-
cause they found the long-term follow-up offered quite
appealing, thought they could choose a treatment and still
be in the RCT. One of them, patient 11 from above,
reflected on the appointment and the decision to choose a
treatment rather than enrolling in the RCT:
Patient 11: he (surgeon) said you have to choose
whether you want to have treatment (a) or whether
you want to have treatment (b). And he explained
them both and really they didn’t seem to make any
difference. He seemed to think that at my age and my
health that it wasn’t a problem having an
anaesthetic, and I said well, I really am ambivalent.
He said ‘no’, go home and read the paperwork and
think about it. And don’t make a decision today. So I
did that, I went home and then I decided I would go
for treatment (b).
Later, on explaining the concept of randomisation dur-
ing the interview, this patient clearly stated willingness
to participate in the trial even if allocated to treatment
(a). She explained that she chose a treatment because
the surgeon said ‘you have to make a decision’, which
was taken to mean a decision on which treatment she
wanted to have rather than on whether she wanted to
participate in the trial or not.
The interviews indicated other missed opportunities
for recruitment such as patients who did not have a
strong treatment preference prior to or during the re-
cruitment appointment - a reflection of the reasonably
well-balanced presentation of information as shown in
Q-QAT and an indication that these patients were in
equipoise and, therefore, ideal candidates for randomisa-
tion. However, similar to patient 11 above, these patients
later chose a treatment because they thought that was
the decision being asked of them and also because they
could not see the link between their uncertainty about
which treatment to have and the rationale for the trial:
SP: did you have any opinion as to what treatment
you might prefer before you went in for this initial
consultation?
Patient 4: no, I didn’t know anything about it to be
quite honest.SP: so when did the fact that you preferred surgery
kind of take shape do you think? During the
consultation, after or?
Patient 4: well, I came home and they sent me
information or I had information about both of them, I
think it was just reading that really, because at the
consultation (surgeon) couldn’t, he explained both the
treatments but he didn’t, I was disappointed that he
couldn’t turn around and say to me, treatment (a)
would be better for you or treatment (b) would be
better for you. So although he explained both
procedures to me, I didn’t really choose there and then
what I was gonna have.
SP: and did (surgeon) kind of explain why he was not
able to choose one treatment for you?
Patient 4: I don’t know, I can’t remember what he
said, why he couldn’t, but I remember asking him but
I can’t think what he said.
A few patients understood some aspects of randomisa-
tion, but without being provided with a clear rationale for
it, found the concept confusing or misunderstood its pur-
pose as solely the generation of equal-numbered groups:
Patient 4: because I was eligible for both of them, I
would benefit from either of the treatments, he said to
me, and it would just be almost picked out of a hat.
SP: was there any reason do you think for the
treatment being chosen in that way?
Patient 4: um, I’m not sure really. I don’t know.
Patient 14: had there been an option where equal
numbers of people said this was the way they wanted
to go, I don’t see why they couldn’t have been in the
trial, you know, they could have still been followed up,
they could have still been kept under scrutiny and the
results would still have been the same because there
were the same number of people.3. Discussion of the Q-QAT and qualitative findings
with RCT1 CI, PI and recruiters
The Q-QAT analysis in RCT1 showed that recruiters
provided a reasonably well-balanced presentation of treat-
ments, but spent very little time explaining the RCT. The
qualitative analysis emphasised that the limited time spent
explaining the RCT did not enable sufficient information
provision for patients to consider the RCT properly. It
also showed that the surgeons were finding it difficult to
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reflected in the patient interviews, which showed that
patients had potentially been in equipoise before, during
and for a brief period after the consultation, but their
uncertainty was not then linked to trial participation or
randomisation, and so patients thought they had to
choose a treatment. In addition, the research nurse was
expected to assist with recruitment, but seemed not to
be aware of this and did not do so.
The findings were discussed with the CI and then
presented to the centre PI and recruiters in other trial
centres. A short document was produced to provide
feedback for recruiters to assist them in providing
clearer information about the RCT and randomisation.
The nurse was encouraged to engage in a more in-
depth patient-led discussion of what RCT participation
involved. At the feedback meetings, recruiters found
the Q-QAT analysis to be a useful tool to visualise the
time breakdown of their appointments and felt that the
qualitative insights helped explain the Q-QAT findings
further. While resources were not available to support
a full evaluation, feedback from recruiters suggestedTable 3 Randomised controlled trial 2 (RCT2) Quanti-Qualitat
seconds, Centre 1
Patients Recruiters Total time
Patient 1 Surgeon A 28:54
Oncologist A 37:34
Patient 2 Surgeon B 35:27
Oncologist B 15:31
Patient 3 Surgeon C 41:00
Oncologist B 25:30
Patient 4 Surgeon C 17:30
Oncologist B 12:52
Patient 5 Surgeon B 42:05
Oncologist B 20:07
Patient 6 Surgeon A 12:59
Oncologist B 09:14
Patient 7 Surgeon D 18:11
Oncologist B 33:08
Centre 1 Total Mean 25:00
Median 22:49
Range 09:14 to 42:05
Centre 1 Surgeons Mean 28:01
Median 28:54
Range 12:59 to 42:05
Centre 1 Oncologists Mean 22:00
Median 20:07
Range 09:14 to 37:34that recruitment improved as a result of the informa-
tion provided during feedback.
Findings from RCT2
In RCT2, there was a more complex recruitment pathway
where patients with the cancer diagnosis had appoint-
ments with both a surgeon and an oncologist to explain
the treatment options and the RCT. All 3 centres agreed
to participate in the qualitative recruitment study, al-
though only 2 actually provided audio-recorded appoint-
ments - 26 pairs in total of which Q-QAT was applied to
the first 11 pairs to facilitate early feedback provision, 7 in
Centre 1 and 4 in Centre 2 (Tables 3 and 4). Q-QAT ana-
lysis was carried out separately by centre and specialty.
1. Q-QAT quantification
The appointments in RCT2 ranged in length from
around 9 to 40 minutes. On average, appointments took
around 30 minutes across both centres - slightly longer
in Centre 2 than Centre 1. The RCT and its treatments


















00:00 to 03:00 00:00 to 08:48 00:00 to 08:01
02:32 01:16 04:11
02:23 01:20 04:06
00:25 to 03:00 00:00 to 03:01 00:50 to 08:01
00:18 03:32 01:01
00:10 03:23 00:40
00:00 to 00:50 00:10 to 08:48 00:00 to 03:15
Table 4 Randomised controlled trial 2 (RCT2) recruiter Quanti-Qualitative Appointment Timing (Q-QAT) timings in
minutes: seconds, Centre 2
Patients Recruiters Total time Surgery Radiotherapy Trial
Patient 8 Surgeon E 31:00 04:50 01.15 02:55
Oncologist C 38:02 00:10 12:38 02:00
Patient 9 Surgeon E 28:02 03:11 01:57 05:35
Oncologist C 31:00 00:15 14:14 01:05
Patient 10 Surgeon E 38:10 03:20 00:00 03:32
Oncologist C 33:31 00:15 00:00 00:00
Patient 11 Surgeon E 28:02 01:19 00:20 01:05
Oncologist D 33:46 01:26 00:52 02:49
Centre 2 Total Mean 32:42 01:51 03:55 02:23
Median 34:31 01:23 01:04 02:25
Range 28:02 to 38:10 00:10 to 04:50 00:00 to 14:14 00:00 to 05:35
Centre 2 Surgeon Mean 31:19 03:10 00:53 03:17
Median 29:31 03:16 00:48 03:14
Range 28:02 to 38:10 01:19 to 04:50 00:00 to 01:57 01:05 to 05:35
Centre 2 Oncologists Mean 34:05 00:32 06:56 01:29
Median 33:39 00:15 06:45 01:33
Range 31:00 to 38:02 00:10 to 01:26 00:00 to 14:14 00:00 to 02:49
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each of the RCT treatments: in both centres, on
average, less time was spent on surgery than
radiotherapy. However, the time spent describing
each treatment varied by specialty in both centres.
On average, surgeons spent more time describing
surgery than radiotherapy and oncologists spent
more time describing radiotherapy than surgery -
and this was consistent across both centres. The
time imbalance appeared more prominent among
oncologists than among surgeons.
(b)Time taken by recruiters to explain the design,
purpose and procedures of the RCT: on average, a
similar, relatively short time was spent in both
centres by all specialists on explaining the RCT. The
Q-QAT analysis indicated that surgeons spent more
time discussing the RCT than oncologists in both
centres.
As in RCT 1, some preliminary conclusions and areas of
further investigation could be drawn from the simple Q-
QAT analysis in RCT2. Recruitment in this RCT was very
difficult - no patients had been recruited (of 14 eligible pa-
tients) across the 3 centres at the time of Q-QAT analysis.
Issues to investigate qualitatively included whether imbal-
ances in the presentation of treatment and RCT informa-
tion by the different specialists was having any influence
on recruitment and whether the time taken to explain the
RCT was sufficient to enable recruitment. Each of these is-
sues was explored.2. Targeted qualitative analysis
(a) Insights from appointments
Analysis of all 26 paired recordings (19 in Centre 1; 7 in
Centre 2) of patient recruitment appointments with both
oncologists and surgeons showed that although specialists
spent more time discussing their own treatment as shown
by Q-QAT, in general, specialists across both centres un-
wittingly tended to convey a subtle bias towards surgery
despite acknowledging that they did not know which treat-
ment was better. Surgery was described using definitive
terms such as ‘cure’, ‘kills the cancer’, ‘gold standard’, ‘phys-
ically removes’ or ‘cuts it away’. Both sets of specialists then
tended to reinforce this by expressing doubts about the ef-
fectiveness of radiotherapy and described it tentatively as
having the ‘chance of killing the tumour’, ‘tries to kill it’,
‘shrinks the tumour’, ‘may be able to treat the tumour’ or
as an option for those who did not want an operation:
Oncologist B, Centre 1: it’s a very difficult decision and
there isn’t a right and a wrong answer and some
people have very clear ideas about what they want to
do, whether it should be an operation, they want to
have it cut out. Other people, the thought of the
operation is just so frightening they opt for the
radiotherapy treatment. But for us, we don’t know
which of these treatments is - is better.
Oncologist C, Centre 2: getting back to what you said
before about eradicating it (tumour) was your word I
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especially in radiotherapy is partly that we do the
treatment and then when you finish you have a scan.
You can still see where the tumour is or where it’s
been ‘cause it’s, then takes time for it to shrink and as
it shrinks, the area that was treated becomes
inflamed and then scarred and you look at the scans
after this sort of treatment and you’re always looking
at it and thinking, ‘is there still tumour there or is
there not?’ and it’s difficult sometimes to assess
response after radiotherapy (three more lines about
assessing the scans). Whereas at least with surgery, as
you say, once it’s cut out, that’s the end of it hopefully
and then the scans that we do are slightly different -
they’re to look to see if there’s any sign of it coming
back and you have scans in the future, er, er, yeah, so
it is, some people do feel that that they want to have it
cut out and that - they feel that that’s gonna be the
end of it.
Surgeon E, Centre 2: now, the upside of the
chemotherapy and the radiotherapy is of course you
don’t need a very big operation. The upside of surgery
is that of course we actually physically remove the
cancerous area and we are able to look at it under the
microscope and see exactly what the nature of it is
and, and so on, but the evidence that we have is that
the two techniques are similar, but we don’t know
whether they’re exactly the same and that is why we’re
doing the study.
The same surgeon later continued as follows:
Surgeon E, Centre 2: the chemotherapy sensitises the
tumour and then the radiotherapy blasts it and tries
to- to- to- kill it. And there have been some very good
results when we do this form of treatment but they’ve
never ever been compared with what has been in - over
many years, the gold standard treatment which is,
with, with an operation
The presentation of information about the RCT was
often very short, with minimal detail, and was some-
times hesitant and unclear:
Patient 2: I mean, what is the trial? That’s what I’m
trying to get at.
Surgeon B, Centre 1: the trial is, we would enter you
into this trial and the trial would choose the option for
you.
Patient 2: does the trial, is it something else that’s
going to start before we actually get the treatment?Surgeon B: no. Er, n- n- n- not quite. The treatment is
either chemotherapy and surgery or chemotherapy and
radiotherapy, and if you agree to enter this trial, we
would choose - well, the study would choose one of
those options for you, at random.
Patient 2: yeah, but what have I got to do for the trial,
this is the point, is what I’m trying to get at.
Surgeon B: you would have that treatment, whichever
one the trial chose for you.
Patient 2: no, I don’t think I’m getting this. This word
trial to me seems to be a completely wrong word. It’s
not a trial, it’s actually what you’re gonna get. It’s the
actual treatment, isn’t it?(b)Insights from interviews with recruitment staff and
patients
Interviews were undertaken with 20 staff and 16 pa-
tients. In their interviews, specialists also used phrases
similar to those in their recruitment consultations to de-
scribe the treatments (surgery ‘cuts out’, ‘physically
removes’ versus radiotherapy ‘shrinks’, ‘sterilises’ ‘keeps the
tumour’). A few showed awareness of their biases and
acknowledged the impact of this language and of an im-
balanced presentation of the treatments on recruitment:
Surgeon G, Centre 1: we can certainly stir up and
reinforce a patient’s bias very easily with a throw away
comment like the aim of the surgery is to cut out your
cancer and that could ruin everything from the point
of view of a balanced randomised trial.
Oncologist B, Centre 1: there was someone who used to
work here who used to say ‘well I can cut away your
tumour or they can shrink it with radiotherapy’, so the
word you use matters a lot because ‘shrink’ gives the
impression that you’re not going to get rid of it,
whereas to cut it out means you’ve taken it away, gives
you the impression that you’re definitely cured.
In Centre 2, some of the surgical bias was attributed
to surgery being considered the ‘gold standard’ in the
centre prior to the trial:
Oncologist E, Centre 2: it is the case though that
historically because we’ve had such a strong surgical
lead to the MDT (Multi-Disciplinary Team meeting),
we’ve got a long history of surgery for that group of
patients (…) I think that it’s not because we think
surgery is better, it’s just that we’ve more experience
and that it’s been a gold standard here for so long.
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erally reflected specialists’ subtle bias towards surgery and
they tended to mirror the language used by the specialists:
Patient 14, Centre 1: so having chemo and
radiotherapy, there’s no guarantee with any of it, but
in my mind, you’re just trying to shrink the tumour
and there is no guarantee that you will do it with that,
but with surgery you’re physically cutting it out.
Centre 1 staff interviews revealed that these biases
were more readily and strongly attributed to surgeons,
by themselves and by oncologists, with only infrequent
acknowledgement of oncologists’ biases and preferences.
In contrast, although patients generally tended to say
they did not think that either of the specialists had a
preference, some patients felt they detected a preference
for radiotherapy among oncologists because they spent
more time explaining radiotherapy:
Patient 4, Centre 1: once or twice I thought is he
(oncologist) trying to persuade you to go for the
radiotherapy and chemotherapy, that was the
impression I got, but I don’t know. (CW: what did he
say that made you think that?). Patient 4: well he sort
of elaborated on it a bit more rather than about the
operation. I had a feeling he was leaning towards that
way. (CW: and when you were with (surgeon) did you
feel was leaning towards the surgery?) Patient 4: no,
(surgeon) explained what surgery would be, what
radiotherapy would be, and said really the decision
will be yours.
In both centres, clinicians’ time and content imbal-
ances in explaining the treatments (Tables 3 and 4) had
consequences as many patients clearly grasped the com-
peting interests of the two clinicians they saw:
Patient 2, Centre 1: my honest opinion was between them
there was a little bit of competition, and that can put
you off a little bit. There shouldn’t be competition in that
sort of a way (…) they might not think so themselves but
there is, yeah. Obviously the surgeon thinks he’s the better
man, the other one thinks he’s the better man.
Patient 14, Centre 1: I know that there is historically
an antipathy between oncology and surgery, different
aspects of looking at things.
Patient 17, Centre 2: I got the impression, and you can
take it whichever way you like, that they knew what
they were doing with their job and the other, they
weren’t quite interested in the other side, if you know
what I mean.Interviews with patients showed that they had very little
knowledge or understanding of the RCT, and confirmed
that discussion about randomisation was absent or very
minimal in the recruitment appointments they had. In
Centre 3 staff interviews and meetings, the oncologists ad-
mitted being sceptical about whether the trial could be
carried out successfully from its outset and readily ques-
tioned surgeons’ commitment to the trial.
3. Discussion of the Q-QAT and qualitative findings
with the RCT CI
In RCT2, the Q-QAT analysis identified two potential
barriers to recruitment: unequal time spent describing
treatments and very little time spent explaining the RCT.
When these were explored further in the qualitative ana-
lysis, they were confirmed as key barriers. There was also
evidence of a lack of equipoise in Centres 1 and 2 among
specialists, with a tendency to prefer surgery. In interviews
with specialists, some acknowledged this bias, its origins
and consequences for recruitment, although most of this
discussion was centred on surgeons being more biased
than oncologists. However, the evidence from the Q-QAT
findings did not support this because there were imbal-
ances in information provision across both specialties.
Patients’ views about treatments reflected those of the
specialists. Although patients tended to say that the spe-
cialists did not appear biased, they sensed the com-
petition between the two specialties. In Centre 3, it
appeared that there were problems with oncologists’ be-
lief in the trial. In general, considerable discomfort was
evident among the specialists in the very short and
sometimes confusing descriptions of the RCT design
and purpose, and inevitably patients’ understanding of
the RCT was very limited.
These findings were discussed with the CI. As Q-QAT
was applied as part of a fully-funded integrated qualita-
tive recruitment study in RCT2, anonymised findings
were then presented at an open meeting to 16 recruiters,
including oncologists, surgeons and representatives from
all 3 centres. The presentation of Q-QAT tables and the
targeted qualitative analysis provoked considerable dis-
cussion amongst recruiters. During the meeting, re-
cruiters from Centre 3 admitted that they did not have
sufficient equipoise and belief in the RCT to take part in
it, and they did not recruit further. Recruiters from
Centres 1 and 2 believed they could achieve equipoise.
Recruiters in Centre 2 approached 10 patients over the
following 15 months, but they continued to favour
surgery and so no patients agreed to join RCT2. In
Centre 1, recruiters approached 16 eligible patients dur-
ing this time, and, in more balanced appointments, 5
patents agreed to be randomised. It was not possible for
RCT2 to recruit sufficient numbers for a full trial.
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For the Q-QAT method to be practicably useful, it was
tested for consistency and reliability by 3 researchers
(SP, SS and CW) coding the appointments in RCTs1 and
2 independently and then comparing coding outcomes
so that guidance could be prepared for future use. The
final refined coding strategy is presented below. It com-
prises six main codes - the original three (a to c) and
three additional codes (d to f ) that emerged as a result
of the blind coding process. Each of the six codes is pre-
sented below with a detailed description of what they
should contain and guidance on the interpretation of
patterns. Figure 1 provides an example of the final cod-
ing process with the start and finish times of examples
of the Q-QAT data items and Table 5 gives a brief out-
line of the coding categories.
Q-QAT coding framework
(a)RCT treatment groups: discussion of intervention
types, processes and outcomes related to each RCT
treatment. Codes: name of Trial group 1, Trial group
2, and so on. Imbalance in time spent betweenTable 5 Quanti-Qualitative Appointment Timing (Q-QAT) coding
Coding categories Content




(Content of each RCT trea




Processes involved in tria
documentation and proc
(c) Total length of appointment Time spent by recruiter a
Everything - from start to
(d) Balancing Time spent by recruiter a
Need for intervention wh
All other intervention opt
Eligibility for any treatmen
Discussion of intervention
(e) TTFMT Time elapsed before first
(Time to first mention of RCT)
(f) Other Time spent by recruiter a
All other issues, including
test results, diagnosis, exa
intervention talktreatments or specialists could suggest underlying
issues with equipoise or preferences for particular
treatments.
(b)RCT design and processes: all aspects of the
presentation of the RCT, including the RCT design
and rationale, eligibility, clinical uncertainty/equipoise,
and processes involved in RCT participation, such as
randomisation, informed consent, follow-up schedules.
Code: trial. Spending little time discussing these issues
could suggest discomfort with the RCT, a lack of
integration of the RCT into clinical practice or
unfamiliarity with recruitment.
(c)Total length of the appointment: the entire
appointment length, from start to finish. Code: total
time. This is useful to calculate the proportion of
time spent discussing the trial and/or the treatments
in relation to the whole appointment.
(d)Balancing of treatments: comparisons of the
advantages, disadvantages and evidence of the RCT
treatments, expressions of uncertainty, justifications
for the need for treatment, and suitability for
treatments not included in the RCT. Code:
balancing. This was added to capture crucial aspectscategories
nd patient discussing:
tment group to be defined for each randomised controlled trial (RCT))
nd patient discussing:





en not in context of RCT
ions available when not in context of RCT
t when not in context of RCT
s involving comparisons, when not in the context of the RCT
mention of RCT
nd patient discussing:
current state of health, history-taking,
mination, and general non-RCT or
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linked to the RCT by the recruiters or when not
already included in codes (a) and (b) above. It was
also added to overcome the challenge of coding
sections where the recruiter constantly moved from
one treatment to another such that each line or turn
in the conversation cannot be accurately timed. This
code is to be used with codes (a) and (b) to indicate
the level of integration of the RCT in the appointment,
and willingness to compare intervention options.
(e)Time to the first mention of the RCT (TTFMT): the
length of time that elapsed before the RCT was
mentioned. Code: TTFMT. This was added to give
an indication of how much the RCT was integrated
into or framed the overall discussion of the
appointment.
(f ) All other matters discussed: all other aspects
discussed in the consultation. Code: other. This was
added to indicate the proportion of the discussion
dedicated to trial recruitment (a, b, d) in comparison
to other aspects, such as, history-taking, examinations
and discussion of other issues.
Coding guidelines
The above codes need to be adapted to suit the particu-
lar RCT design in terms of the number and type of in-
terventions available. Transcripts or audio-recordings of
appointments must be available. Recruiter and patient
contributions to the Q-QAT data items should be in-
cluded in the coded timings to capture the time spent
‘discussing’ them. Codes can then be applied systematic-
ally and raw times (and means, medians and ranges) cal-
culated to produce the Q-QAT findings that can then be
discussed with the RCT CI to identify areas for targeted
qualitative analysis. The technique is simple enough to
be applied by a single researcher, although blind coding
by another researcher increases the consistency and reli-
ability of coding. It can be used as a stand-alone tech-
nique to identify potential recruitment barriers and
provide recruiters with an easy overview of the recruit-
ment process, although its real strength emerges when
integrated with qualitative data analysis. Data from Q-
QAT can be compared in various ways, for example, by
centre, specialty, or particular recruiter.
Discussion
This paper has presented the development, application
and guidance for use of a new technique to rapidly iden-
tify recruitment issues in ongoing RCTs, particularly fo-
cusing on the presentation of information to potential
participants by recruiters. The Quanti-Qualitative Ap-
pointment Timing (Q-QAT) technique incorporates
simple quantitative techniques integrated with targeted
qualitative approaches, allowing the rapid identificationof potential difficulties and findings to aid understanding
of underlying issues that can be addressed to improve
RCT recruitment. The technique was developed in a
programme of research employing primarily qualitative
research methods to understand recruitment issues in
six RCTs [9,11]. In this study the technique has been ap-
plied directly to two RCTs in different clinical contexts
with recruitment difficulties of unknown origin.
Used as a stand-alone technique, Q-QAT rapidly identi-
fied weaknesses in information provision and potential re-
cruitment barriers, such as minimal time spent explaining
the RCT, and variations in time spent explaining the RCT
treatments. Although these issues could only be fully
understood when explored qualitatively, the initial pat-
terns that emerged from the Q-QAT tables enabled
‘targeted’ qualitative analysis to facilitate a detailed and nu-
anced understanding of issues related to the presentation
of the RCT. These combined findings were then presented
to the RCT CI, so that a plan of action to improve recruit-
ment practice could be initiated, including engaging re-
cruiters in discussion of issues that are often hidden and
uncomfortable, including aspects of equipoise and patient
eligibility [13,14]. We presented the findings directly to
the CI and then to individual recruiters and anonymously
in group meetings. Feedback meetings can use the frame-
work in Tables 2 and 3, and these tend to provoke consid-
erable discussion. However, the particular process of
feedback and discussion needs to be flexible in relation to
the particular RCT and agreed with the RCT CI.
The idea for the technique emerged from a re-
assessment of findings from qualitative research in previ-
ous RCTs [7,9,11]. Imbalanced information provision
was a frequent finding and a key recruitment problem in
these RCTs. While recognising the importance of rou-
tinely integrating fully fledged and comprehensive quali-
tative research into difficult RCTs [9], there was also a
pressing need to identify simpler techniques aimed at
rapidly understanding the reasons for difficulties that
arise from the recruitment appointment. Ideally, such
techniques should be applicable across a wide range of
trial recruitment discussions, which can occur in the
context of general clinical consultations or dedicated re-
cruitment appointments. The Q-QAT technique was
successful when applied to the two RCTs with recruit-
ment difficulties described in this paper, which were se-
lected to include simple and more complex recruitment
pathways, an elective compared with life-threatening
condition, and involving one clinical specialty or two.
The technique received positive feedback from recruiters
in both RCTs, and, when fully supported, helped im-
prove recruitment in RCT2, as had an earlier informal
version of the technique [7].
Time spent in discussion with patients has previously
been considered in primary care settings, not in relation
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but in relation to the total length of the consultation and
its influence on aspects such as patient/physician satis-
faction [16,17]. Increasing the length of the consultation
does not always improve patient satisfaction, with the
quality of the information provision found to be of
greater importance [17,18]. RCTs are widely acknowl-
edged as constituting the highest form of evidence to
demonstrate the effectiveness of an intervention and yet
the time spent by recruiters in discussing RCTs with pa-
tients has not previously been examined. The Q-QAT
analysis quickly identified that very little time was spent
during appointments on presenting or explaining the
RCT, and that more time was needed to assist partici-
pant understanding. This could be achieved while retain-
ing the same length of appointment by integrating the
RCT discussion more effectively with the clinical issues,
including mentioning the RCT earlier, and avoiding
some repetition of treatment details.
There are some limitations to the study presented in
this paper and the Q-QAT technique. The technique
was developed during research with six RCTs and then
applied formally only in two simple parallel-group treat-
ment trials, and so it is possible that researchers apply-
ing the technique more widely might face different
challenges to those described here. We attempted to ad-
dress some of the limitations through the process of
blind coding by three researchers to ensure that the six
coding categories could be accurately, rapidly and con-
sistently applied, and guidelines have been presented
that standardise the technique. Although there were var-
iations in the clinical context and complexity of the two
RCTs presented in this study, the coding strategy was
easily adapted to address these differences. The Q-QAT
analysis required coding of audio-recordings or tran-
scripts of appointments, which could then produce rela-
tively rapid but somewhat crude quantitative findings
identifying imbalances and time spent on the presenta-
tion of aspects of the RCT. Targeted qualitative research
was then crucial to understand the quality of the infor-
mation presented and its impact on recruitment.
Q-QAT was developed to be a technique that was spe-
cific enough to capture the amount of time spent discuss-
ing the key aspects of a RCT, but also sufficiently generic
to be applied to RCTs of different designs and complex-
ities. It is likely to be particularly useful for RCTs where
recruitment is persistently difficult, even when other inter-
ventions have been tried. Q-QAT can be applied as a
‘trouble-shooting’ device when recruitment has been poor
for some time, or as an integral part of a pilot or feasibility
study where recruitment is predicted to be difficult - for
example where there are marked differences between the
arms, or one arm involves a very conservative manage-
ment strategy compared with an interventional one, as inmany RCTs involving surgery. The findings of the Q-QAT
analysis might then inform aspects of the design or con-
duct of the main trial or identify recruiter training needs.
In other cases, as in RCT2 here, it can provide information
needed to enable an appropriate decision about whether
or not to proceed with the transition to a large-scale RCT
or further recruitment, providing essential information to
convince a funder whether recruitment can or probably
cannot be achieved.
The Q-QAT technique is now available as a stand-
alone intervention to assist in understanding RCT re-
cruitment and needs to be evaluated more thoroughly.
Further work will be undertaken to evaluate the Q-QAT
technique’s ability to identify training needs for RCT
staff, as part of a wider, more complex intervention
using mixed research methods to improve recruitment
to RCTs while maintaining high levels of informed con-
sent. This could include assessments of the quantity and
quality of information between specialties or individual
recruiters, as seen in RCT2. Further future work may
consider the potential for the translation of the Q-QAT
technique to other contexts, including as part of con-
tinuing monitoring of RCT recruitment efficiency and
effectiveness, and perhaps within routine clinical prac-
tice in primary or secondary care.Conclusions
In conclusion, the Q-QAT technique is a novel and sim-
ple technique that can be used to identify and under-
stand potential barriers to recruitment within RCT
appointments. It can be used as a stand-alone technique
to rapidly identify issues, but is more informative when
followed by targeted qualitative analysis aimed at under-
standing the reasons for the patterns identified. The
quanti-qualitative findings can then be discussed with
RCT CIs, and used to develop strategies to improve re-
cruitment and engage recruiters in discussing underlying
issues that may be hidden or uncomfortable [13,14]. The
technique’s ease of use and ability to provide useful in-
sights into recruitment problems in a short time frame
are key attributes that make it suitable for use in RCTs
underway with recruitment difficulties and in feasibility/
pilot studies developing RCTs with expected recruitment
challenges.
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